Search research articles
Contact Us
Filters
Showing results (21-30 of 39) with videos related to
Page
of 4
Sort By:
Oncoimmunology
|
May 10, 2019
Clinical significance of CD8<sup>+</sup> T cell immunoreceptor with Ig and ITIM domains<sup>+</sup> in locally advanced gastric cancer treated with SOX regimen after D2 gastrectomy
Weiwei Tang, Xiongxiong Pan, Di Han, et al.
Frontiers in Cell and Developmental Biology
|
September 27, 2021
Role of Small Molecule Targeted Compounds in Cancer: Progress, Opportunities, and Challenges
Guoqiang Sun, Dawei Rong, Zhouxiao Li, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
September 21, 2022
CircPAK1 promotes the progression of hepatocellular carcinoma via modulation of YAP nucleus localization by interacting with 14-3-3ζ
Xiaopei Hao, Yao Zhang, Xiaoli Shi, et al.
Journal of Oncology
|
December 20, 2021
Morbidity, Prognostic Factors, and Competing Risk Nomogram for Combined Hepatocellular-Cholangiocarcinoma
Xiaoyuan Chen, Yiwei Lu, Xiaoli Shi, et al.
Molecular Therapy. Nucleic Acids
|
June 30, 2021
Epigenetics: Roles and therapeutic implications of non-coding RNA modifications in human cancers
Dawei Rong, Guangshun Sun, Fan Wu, et al.
Molecular Therapy Oncolytics
|
May 24, 2021
Single-cell RNA sequencing in cancer: Applications, advances, and emerging challenges
Guangshun Sun, Zhouxiao Li, Dawei Rong, et al.
Cancer Cell International
|
October 12, 2022
Midazolam exhibits antitumour and enhances the efficiency of Anti-PD-1 immunotherapy in hepatocellular carcinoma
Junwei Kang, Zhiying Zheng, Xian Li, et al.
International Journal of Biological Sciences
|
September 23, 2022
Tumor Microenvironment and its Implications for Antitumor Immunity in Cholangiocarcinoma: Future Perspectives for Novel Therapies
Hengsong Cao, Tian Huang, Mingrui Dai, et al.
Journal of Gastrointestinal Oncology
|
January 10, 2024
Efficacy and safety of regorafenib in combination with immune checkpoint inhibitor therapy as second-line and third-line regimen for patients with advanced hepatocellular carcinoma: a retrospective study
Jie Zhao, Yongzhong Guo, Tianshuo Feng, et al.
Molecular Therapy. Nucleic Acids
|
October 27, 2021
m6A modification of circHPS5 and hepatocellular carcinoma progression through HMGA2 expression
Dawei Rong, Fan Wu, Chen Lu, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 39) with videos related to
Sort By:
Page
of 4
Oncoimmunology
|
May 10, 2019
Clinical significance of CD8<sup>+</sup> T cell immunoreceptor with Ig and ITIM domains<sup>+</sup> in locally advanced gastric cancer treated with SOX regimen after D2 gastrectomy
Weiwei Tang, Xiongxiong Pan, Di Han, et al.
Frontiers in Cell and Developmental Biology
|
September 27, 2021
Role of Small Molecule Targeted Compounds in Cancer: Progress, Opportunities, and Challenges
Guoqiang Sun, Dawei Rong, Zhouxiao Li, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
September 21, 2022
CircPAK1 promotes the progression of hepatocellular carcinoma via modulation of YAP nucleus localization by interacting with 14-3-3ζ
Xiaopei Hao, Yao Zhang, Xiaoli Shi, et al.
Journal of Oncology
|
December 20, 2021
Morbidity, Prognostic Factors, and Competing Risk Nomogram for Combined Hepatocellular-Cholangiocarcinoma
Xiaoyuan Chen, Yiwei Lu, Xiaoli Shi, et al.
Molecular Therapy. Nucleic Acids
|
June 30, 2021
Epigenetics: Roles and therapeutic implications of non-coding RNA modifications in human cancers
Dawei Rong, Guangshun Sun, Fan Wu, et al.
Molecular Therapy Oncolytics
|
May 24, 2021
Single-cell RNA sequencing in cancer: Applications, advances, and emerging challenges
Guangshun Sun, Zhouxiao Li, Dawei Rong, et al.
Cancer Cell International
|
October 12, 2022
Midazolam exhibits antitumour and enhances the efficiency of Anti-PD-1 immunotherapy in hepatocellular carcinoma
Junwei Kang, Zhiying Zheng, Xian Li, et al.
International Journal of Biological Sciences
|
September 23, 2022
Tumor Microenvironment and its Implications for Antitumor Immunity in Cholangiocarcinoma: Future Perspectives for Novel Therapies
Hengsong Cao, Tian Huang, Mingrui Dai, et al.
Journal of Gastrointestinal Oncology
|
January 10, 2024
Efficacy and safety of regorafenib in combination with immune checkpoint inhibitor therapy as second-line and third-line regimen for patients with advanced hepatocellular carcinoma: a retrospective study
Jie Zhao, Yongzhong Guo, Tianshuo Feng, et al.
Molecular Therapy. Nucleic Acids
|
October 27, 2021
m6A modification of circHPS5 and hepatocellular carcinoma progression through HMGA2 expression
Dawei Rong, Fan Wu, Chen Lu, et al.
Page
of 4